Check out our editorial in #JACCInterventions discussing an interesting manuscript “PPCI in Patients With #SCAD vs CAD” by Alfonso et al. Editorial: “SCAD Causing AMI: Is Revascularization the Best Course of Action?” 👉sciencedirect.com/science/articl… JACC Journals Jacqueline Saw #AjayKirtane

Way to go Chetan Huded 👏🏼👏🏼👏🏼

💯 #DocsWhoRock

Trying to stent SCAD…

In STEMI patients with a large myocardial area at risk, prehospital administration of crushed prasugrel tablets, compared to integral tablets, leads to improved postprocedural TIMI 3 flow rates. This suggests that crushed prasugrel may offer a more effective, safe, and

1 in 5 adults have an Lp(a) level that is too high. Use #CardioSmart’s Lp(a) Infographic to help patients understand this condition and how it might affect their heart. bit.ly/40ys3ta #Cholesterol #ACC24

💊 Aspirin to ⬇️ risk for preeclampsia has been supported by robust studies, and shows significant benefits for moderate to high-risk patients. A recent article has sparked some discussion on the removal of race from the USPSTF risk equations (1/4) nejm.org/doi/full/10.10…

Presented today at #ACC24: In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t

In the SMART trial of TAVR in patients with a small aortic annulus, a self-expanding valve was noninferior to a balloon-expandable valve for clinical outcomes and was superior for bioprosthetic-valve dysfunction through 12 months. Full results: nej.md/49p7VO7 #ACC24

ULTIMATE DAPT trial showed in pts with ACS treated with PCI, ticagrelor monotherapy btw 1 and 12 months decreased clinically-relevant and major bleeding, had similar protection from MACCE vs DAPT (ticagrelor + aspirin).

ULTIMATE-DAPT: Most Patients With #cvACS Can Safely Stop Aspirin One Month Post #PCI Learn more about the results of ULTIMATE-DAPT trial presented at #ACC24: bit.ly/43RFpDO

Really important work presented by Dr Lori Tam on behalf of iSCADregistry. n=1414 patients in 5 years is a testament to the power of collaboration in the science of rare/uncommon disease. SCAD Alliance Providence Malissa Wood Katherine K Leon

A long-waited PREVENT trial is now presented at LBCT-V #ACC2024 🇰🇷From the inception of trial to completion of trial took a decade. ✅1,606 pts with intracoronary imaging-detected “Vulnerable Plaque” randomized 1:1 to (1) Preventive PCI vs (2) OMT alone. ✅Prevent PCI

In the PREVENT trial, preventive PCI plus OMT resulted in a lower incidence of MACE vs. OMT alone in pts with non-flow-limiting vulnerable plaques

It’s totally in vogue to get your lipoprotein a Lp(a) level checked once in your life (value doesn’t change much after 5 years of age). Lp(a) is a marker of cardiovascular disease and calcific AS. American College of Cardiology had a booth to get yours! #prevention Ashley Waring #lipids

RENAL DENERVATION IN THE MANAGEMENT OF HYPERTENSION This new State-of-the-Art: ✅ summarises the rationale for RDN, ✅ reviews the available evidence, ✅ provides recommendations for a safe procedure, ✅ discusses the role of RDN in current guidelines and clinical practice.

IC Fellowship Graduation 2024✨ Hands down the best year of training so far! Thankful for amazing Saint Luke's Mid America Heart Institute attendings, outstanding mentor and our Teacher of the Year J Aaron Grantham JAG, program director Dr. Hart, co-fellow Anas T. Noman and my husband Elliott Goodwin 🤍

IC Graduation “Toast” & Fellow Farewell 6/20/24 🤍🥹🫀🫶🏼✨🌟Saint Luke's Mid America Heart Institute J Aaron Grantham JAG Anas T. Noman

Happy to share that the Saint Luke's Mid America Heart Institute team was the first in the region to perform transcatheter tricuspid valve replacement using the Edwards Evoque Valve. This device is commercially approved to treat TR and improve symptoms of heart failure.  Saint Luke's Adnan Chhatriwalla